Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Improving the health of vulnerable communities and changing lives is at the heart of what we do and who we are.
One potential impact of the roll-out of malaria interventions, including mass drug administration (MDA), is malaria rebound after elimination which is thought to be due to the loss of naturally acquired malaria immunity. However, the timelines for this is unknown and is required in order to inform appropriate malaria interventions and surveillance strategies.
Utilising data from malaria intervention trials in the Greater Mekong region, we seek to quantify the impact of malaria control measures including MDA (and therefore potential elimination) on malaria immunity within communities and how this predicts epidemiological patterns of disease over time.
Jan 2015 – Feb 2023
NHMRC
For any general enquiries relating to this project, please contact:
Deputy Program Director, Maternal, Child and Adolescent Health
To create and translate knowledge into better health, so no-one is left behind.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2023 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present.
We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.
